1. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: Comparison with inhibitors of HMG-CoA reductase;Amin;J Pharmacol Exp Ther,1997
2. Hepatic cholesterol metabolism in estrogen-treated men;Angelin;Gastroenterology,1992
3. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase;Aoki;Arzneimittelforschung,1997
4. Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation;Aviram;Atherosclerosis,1998
5. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia;Bakker-Arkema;J Am Med Assoc,1996